UCB S.A. | Large-cap | Healthcare

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 6.2B
Gross Profit 4.4B 71.52%
Operating Income 864.0M 14.04%
Net Income 1.1B 17.31%

Balance Sheet Metrics

Total Assets 17.3B
Total Liabilities 7.3B
Shareholders Equity 10.0B
Debt to Equity 0.73

Cash Flow Metrics

Operating Cash Flow 605.0M
Free Cash Flow 920.0M

Revenue & Profitability Trend

UCB S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue6.2B5.3B5.5B5.8B5.3B
Cost of Goods Sold1.8B1.7B1.7B1.4B1.4B
Gross Profit4.4B3.5B3.8B4.3B4.0B
Operating Expenses4.1B3.5B3.4B3.2B3.1B
Operating Income864.0M633.0M701.0M1.3B1.0B
Pre-tax Income1.2B441.0M511.0M1.2B880.0M
Income Tax98.0M98.0M91.0M170.0M119.0M
Net Income1.1B343.0M418.0M1.1B761.0M
EPS (Diluted)-€1.76€2.14€5.45€3.77

Income Statement Trend

UCB S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets4.8B3.4B3.3B3.7B3.6B
Non-Current Assets12.6B12.1B12.6B10.5B9.7B
Total Assets17.3B15.5B15.9B14.2B13.3B
Liabilities
Current Liabilities3.5B2.6B3.1B2.8B2.8B
Non-Current Liabilities3.8B3.9B3.7B3.0B3.2B
Total Liabilities7.3B6.6B6.8B5.8B6.0B
Equity
Total Shareholders Equity10.0B9.0B9.1B8.4B7.3B

Balance Sheet Composition

UCB S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income1.1B343.0M418.0M1.1B732.0M
Operating Cash Flow605.0M78.0M531.0M683.0M396.0M
Investing Activities
Capital Expenditures-234.0M-238.0M-252.0M-281.0M-255.0M
Investing Cash Flow370.0M-358.0M-1.5B-261.0M-2.1B
Financing Activities
Dividends Paid-259.0M-252.0M-247.0M-240.0M-235.0M
Financing Cash Flow-605.0M-119.0M190.0M-1.0B1.3B
Free Cash Flow920.0M445.0M748.0M1.1B732.0M

Cash Flow Trend

UCB S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 30.73
Forward P/E 24.68
Price to Book 3.21
Price to Sales 5.23
PEG Ratio 24.68

Profitability Ratios

Profit Margin 17.31%
Operating Margin 15.53%
Return on Equity 11.21%
Return on Assets 3.22%

Financial Health

Current Ratio 1.36
Debt to Equity 30.17
Beta 0.26

Per Share Data

EPS (TTM) €5.51
Book Value per Share €52.77
Revenue per Share €32.38

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
ucb32.2B30.733.2111.21%17.31%30.17
NewtekOne 19.0M-0.39-10.84%-13.88%33.33
KBC Group NV 34.6B10.221.4714.07%30.84%2.30
Groupe Bruxelles 8.7B295.420.630.82%0.49%50.03
KBC Ancora SCA 4.4B11.821.2310.46%0.00%2.81
Brederode S.A 3.3B8.040.8010.45%109.70%0.00

Financial data is updated regularly. All figures are in the company's reporting currency.